MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2026 International Congress

    Sex comparisons for co-pathologies and clinical phenotypes in autopsy-confirmed four-repeat tauopathies

    E. Bayram, D. Carter, S. Aslam, E. Forbes, S. Holden (Aurora, USA)

    Objective: To assess whether co-pathologies and clinical phenotypes in people with four-repeat tauopathies (progressive supranuclear palsy [PSP], corticobasal degeneration [CBD]) differ by sex. Background: PSP…
  • 2026 International Congress

    Probable Corticobasal Syndrome Presenting as Writer’s Cramp: A Case Report

    B. Dias, K. Alves, T. Goncalves, D. Faria, R. Pinto, S. Silva (Sao Paulo, Brazil)

    Objective: To describe an unusual initial presentation of corticobasal syndrome manifesting as writer’s cramp, a task-specific focal dystonia, and to discuss its compatibility with the…
  • 2026 International Congress

    Amyloid PET–Guided Anti-amyloid Therapy in Corticobasal Syndrome Associated with Clinical Improvement

    S. Fujioka, Y. Nagaishi, T. Imamura, H. Minagawa, K. Uwatoko, M. Yukitake, J. Kira, Y. Tsuboi (Chiba, Japan)

    Objective: To clarify the clinical significance of amyloid positron emission tomography (PET) in patients presenting with corticobasal syndrome (CBS) and to describe the potential therapeutic…
  • 2026 International Congress

    Real-World Survival, Healthcare Access, and Medication Patterns in Atypical Parkinsonian Disorders: A Multi-System EHR Analysis

    J. Fenn, N. Mcfarland (Gainesville, USA)

    Objective: To assess regional prevalence, demographics, survival, neurology access, and medication utilization in atypical parkinsonian disorders. Background: Progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and…
  • 2026 International Congress

    Sex Differences in Disease Severity and Impact for Progressive Supranuclear Palsy and Corticobasal Syndrome

    D. Carter, M. Schina, Y. Wang, G. Nager, A. Sheridan, L. Forsberg, H. Heuer, B. Boeve, A. Boxer, H. Rosen, S. Holden, E. Bayram (Aurora, USA)

    Objective: Assess sex differences in disease severity, quality of life (QOL) and caregiver burden in early- and late-onset progressive supranuclear palsy (PSP) and corticobasal syndrome…
  • 2026 International Congress

    Mirrored-Self Misidentification Expands the Neuropsychiatric Spectrum of Corticobasal Syndrome

    T. Gonçalves, K. Alves, B. Sampaio, L. Berchielli, R. Pinto, S. Silva (São Paulo, Brazil)

    Objective: To describe mirrored-self misidentification (MSM) occurring in corticobasal syndrome (CBS) without early dementia Background: CBS is a neurodegenerative syndrome characterized by asymmetric parkinsonism and…
  • 2026 International Congress

    Corticobasal Syndrome: A Single-Center Retrospective Review

    E. Krening, T. Kaneko, M. Bruno (Honolulu, USA)

    Objective: To characterize the demographic, clinical and diagnostic features of patients diagnosed with corticobasal syndrome (CBS) seen at The Queen’s Medical Center in Honolulu, Hawaii.…
  • 2025 International Congress

    Subacute Unmasking of AD-CBS Subtype

    L. Farese, P. Prakash, J. Drake, S. Estrada (Providence, USA)

    Objective: To describe a unique case of Alzheimer's Disease in which olanzapine use resulted in unmasking an underlying corticobasal syndrome Background: Corticobasal Syndrome is a…
  • 2025 International Congress

    Clinical subtypes and Radiological patterns in Progressive supranuclear palsy: A Prospective study

    K. Gulati, S. Pandey (Faridabad, India)

    Objective: To subclassify Progressive supranuclear palsy (PSP) into cortical and subcortical typesTo identify the clinical and radiological correlation in PSP Background: The 2017 International Parkinson…
  • 2025 International Congress

    The heterogenous compatibility of FDG-PET patterns and tau deposition in vivo in patients with Corticobasal Syndrome

    X. Li, JY. Lu, FT. Liu, J. Wang (Shanghai, China)

    Objective: In this study, we aimed to compare the patterns of 18Fluorodeoxyglucose PET (FDG-PET) with 18F-Florzolotau PET in patients with Corticobasal Syndrome (CBS), and investigate…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley